The Top Three Age Reversal and Age Extension Stocks

Please note that this is a sister publication of WallStreetNewsNetwork ( https://WStNN.com ) and eventually everything on this site will be transferred over there.

by Fred Fuld III

The baby boomers are getting older, and as they age, they become more concerned about their health, living as long as they can, and living as healthy as they can. The boomers get concerned about age related illnesses and diseases that can affect them.

Fortunately, there are a few companies involved in targeting human aging and degenerative diseases. There are many companies involved in developing treatments and cures for many diseases, such as cancer, and may have a small part of their business involved in age reversal. But there aren’t many companies involved age extension as a pure play. Here are a few longevity stocks worth doing further research on.

Cohbar (CWBR) is a clinical stage biotechnology company which concentrates  on the research and development of mitochondria based therapeutics, an emerging class of drugs for the treatment of chronic and age-related diseases. CohBars therapeutics offer the potential to treat a broad range of diseases, including nonalcoholic steatohepatitis, obesity, fibrotic diseases, cancer, acute respiratory distress syndrome, type 2 diabetes, and cardiovascular and neurodegenerative diseases. The company is even in a pre-clinical program for COVID-19 associated ARDS. This  Menlo Park, California based company was founded in 2007. The stock has a market cap of $97 million and has been generating negative earnings. It has $12.5 million in total cash and long term debt of $3.4 million.

AgeX Therapeutics, Inc. (AGE) is an Alameda, California based biotechnology company founded in 2017, with a great stock ticker symbol.The company develops and commercializes novel therapeutics targeting human aging. The company’s two major proprietary technologies are PureStem® and induced Tissue Regeneration (iTR™). PureStem® can generate pluripotent stem cell-derived young cells of any type for potential application in a range of degenerative diseases of aging with a high unmet medical need. iTR™ is the company’s longevity platform with a goal of unlocking cellular immortality and regenerative capacity to reverse age-related changes in the body. The stock has a market cap of $32 million and has been generating negative earnings. It has $2.3 million in total cash and $1.5 million in long term debt.

resTORbio, Inc. (TORC) is a Boston, Massachusetts based company founded in 2016, which is involved in developing innovative medicines that target the biology of aging to prevent or treat aging-related diseases. The company’s lead clinical program is selectively targeting TORC1, an evolutionarily conserved pathway that contributes to the age-related decline in function of multiple organ systems, including neurologic function. Inhibition of TORC1 has the potential to improve the function of aging organ systems and address multiple aging related diseases. The stock has a market cap of $77 million and has been generating negative earnings. It has total cash of $91 million and virtually no long term debt.

Please be aware that these are extremely low cap stocks and should be considered very speculative.

Disclosure: Author owns CWBR.

INVESTMENT TRIVIA    MAKES A GREAT GIFT!!!
 

Try the Warren Buffett-style Stock Analyzer for FREE!

The Top Ten Infrastructure Stocks

Please note that this is a sister publication of WallStreetNewsNetwork ( https://WStNN.com ) and eventually everything on this site will be transferred over there.

by Fred Fuld III

Just one week ago, President Trump’s administration announced a $1 trillion infrastructure proposal to stimulate the economy. Then just four days ago, the House Democrats came up with a $1.5 trillion infrastructure bill.

This huge amount of money should not only help the economy but should also benefit certain stocks involved in the infrastructure business. Here is a list of ten infrastructure stocks that could show an increase in revenues, earnings, and stock price due to the money flowing into this arena.

Arcosa (ACA) provides infrastructure-related products and solutions for the construction, energy, and transportation markets, including commercial, industrial, road and bridge, and underground construction. The stock has a price to earnings ratio of 17 and pays a yield of 0.5%.

Construction Partners, Inc. (ROAD) is an infrastructure and road construction company, providing products and services to public and private infrastructure projects, such as highways, roads, bridges, airports, and commercial sites. The stock has a price to earnings ratio of 22 and does not pay a dividend.

Primoris Services Corporation (PRIM) is a specialty contractor and infrastructure company, which provides construction, fabrication, maintenance, replacement, and engineering services, including highway and bridge construction, airport runway and taxiway construction, and demolition. The stock has a P/E ratio of 11 and pays a yield of 1.4%.

Tutor Perinin (TPC) is a construction company that provides diversified general contracting, construction management, and design-build services. The company has been generating negative earnings and does not pay a dividend.

Nucor (NUE) manufactures and sells steel and steel products used in numerous infrastructure projects. The stock has a P/E ratio of 16.5 and pays a yield of 3.8%.

Vulcan Materials (VMC) produces and markets construction aggregates, asphalt mix and ready-mixed concrete for highways, airports, and government buildings. The stock has a P/E ratio of 26 and pays a yield of 1.1%.

Martin Marietta Materials (MLM) is a major supplier of aggregates and heavy building materials. The stock has a P/E ratio of 22 and pays a yield of 1.0%.

Aecom (ACM) is a provider of design, engineering, and construction services. The company has been generating negative earnings and does not pay a dividend.

Caterpillar (CAT) is a heavy equipment manufacturer with products used in infrastructure. The stock has a P/E ratio of 13 and pays a yield of 3.2%.

Granite Construction (GVA) is an infrastructure contractor and a construction materials producer. The company has been generating negative earnings but pays a dividend of 2.7%.

Disclosure: Author didn’t own any of the above at the time the article was written.

INVESTMENT TRIVIA    MAKES A GREAT GIFT!!!
 

Try the Warren Buffett-style Stock Analyzer for FREE!